Anticipating Heron Therapeutics' Breakout on Phase 3 Results
AI Prediction of Heron Therapeutics, Inc. (HRTX)
Heron Therapeutics, with its robust pipeline and strong R&D focus, is poised for potential growth driven by upcoming catalysts, including a major Phase 3 clinical trial result. The company's strategic focus on pharmaceutical preparations positions it well in the biotech sector for a potential breakout.
HRTX Report Information
Prediction Date2025-07-03
Close @ Prediction$2.20
Mkt Cap59m
IPO DateN/a
AI-derived Information
Recent News for HRTX
- Aug 25, 8:17 am — Heron Intelligence and Paragon Intel merge to create the world's largest management insights provider (PRNewswire RSS)
- Aug 14, 4:30 pm — HRTX files 8-K with regulatory language (ScanScor Filing Bot)
- Aug 13, 7:00 am — Heron Power Selects First Factory Location to Build Next-Generation Power Electronics in the United States (PRNewswire RSS)
- Aug 11, 10:00 am — Heron Automates SMB Underwriting's Last Manual Step: The Background Check (PRNewswire RSS)
- Aug 10, 5:01 pm — Heron Therapeutics Inc (HRTX) (Q2 2026) Earnings Call Highlights: Revenue Growth Amid Strategic ... (GuruFocus.com)
- Aug 10, 11:05 am — Heron Therapeutics Withdraws 2026 Guidance as CINVANTI Patent Risk and Strategic Review Cloud Outlook (InvestorsHub)
- Aug 10, 8:06 am — Heron Therapeutics: Q2 Earnings Snapshot (Associated Press)
- Aug 10, 8:00 am — HRTX SEC filing points to financing activity (ScanScor Filing Bot)
- Aug 10, 8:00 am — HRTX files 8-K with clinical-trial language (ScanScor Filing Bot)
- Aug 10, 8:00 am — Heron Therapeutics Announces Second Quarter 2026 Financial Results (GlobeNewswire RSS)
- Jul 29, 10:00 am — NBS Halves Underwriting Time and Reviews 25-40% More Submissions a Day with Heron (PRNewswire RSS)
- Jul 27, 8:30 am — Heron Therapeutics to Report Second Quarter 2026 Financial Results on Monday, August 10, 2026 (GlobeNewswire)
Welcome to ScanScor. What you're reading is no ordinary summary -- it's the result of a carefully-crafted interactive session with OpenAI's most advanced models crafted from news, trial details, and financial data. This report attempts to maximize the potential for OpenAI's smartest GPT-based analysis engine, guided by tightly structured prompts to expose the forces behind today's market movers and to predict the future.
Disclaimer: This report is for informational purposes only. It does not constitute financial advice. Always do your own research before making any investment.